Paper39201632
Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review.
Enzel D and 3 others. Int J Mol Sci, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review. Papers, record 39201632. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201632
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vitamin D | Major topic |
| Humans | |
| Animals | |
| Idiopathic Pulmonary Fibrosis | |
| Signal Transduction | |
| Pulmonary Fibrosis | |
| Transforming Growth Factor beta |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 23-15-20015 | Russian Science Foundation | PubMed |
Source PubMed
References149
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28034764 | The concept of the personal vitamin D response index. | J Steroid Biochem Mol Biol | 2018 | https://conductscience.org/library/papers/28034764 | PubMed |
| 2 | 35938712 | Immunomodulatory treatment of interstitial lung disease. | Ther Adv Respir Dis | 2022 | https://conductscience.org/library/papers/35938712 | PubMed |
| 3 | 26064885 | Intratracheal Bleomycin Aerosolization: The Best Route of Administration for a Scalable and Homogeneous Pulmonary Fibrosis Rat Model? | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26064885 | PubMed |
| 4 | 38843105 | Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial. | Am J Respir Crit Care Med | 2024 | https://conductscience.org/library/papers/38843105 | PubMed |
| 5 | 35798357 | Plasma cell but not CD20-mediated B-cell depletion protects from bleomycin-induced lung fibrosis. | Eur Respir J | 2022 | https://conductscience.org/library/papers/35798357 | PubMed |
| 6 | 29074545 | Idiopathic pulmonary fibrosis: lessons from clinical trials over the past 25 years. | Eur Respir J | 2017 | https://conductscience.org/library/papers/29074545 | PubMed |
| 7 | 28878195 | 1α,25-dihydroxyvitamin D3 Attenuates TGF-β-Induced Pro-Fibrotic Effects in Human Lung Epithelial Cells through Inhibition of Epithelial-Mesenchymal Transition. | Nutrients | 2017 | https://conductscience.org/library/papers/28878195 | PubMed |
| 8 | 36903624 | Macrophage Polarization: An Important Candidate Regulator for Lung Diseases. | Molecules | 2023 | https://conductscience.org/library/papers/36903624 | PubMed |
| 9 | 37061683 | Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis. | Respir Res | 2023 | https://conductscience.org/library/papers/37061683 | PubMed |
| 10 | 12383190 | Time course of bleomycin-induced lung fibrosis. | Int J Exp Pathol | 2002 | https://conductscience.org/library/papers/12383190 | PubMed |
| 11 | 26627341 | Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. | Sci Rep | 2015 | https://conductscience.org/library/papers/26627341 | PubMed |
| 12 | 22684844 | Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis. | EMBO Mol Med | 2012 | https://conductscience.org/library/papers/22684844 | PubMed |
| 13 | 37083059 | Effect and mechanism of imbalance via Th9 cells and Th17/Treg cells in inflammatory and fibrotic phases of pulmonary fibrosis in mice. | Biotechnol Genet Eng Rev | 2024 | https://conductscience.org/library/papers/37083059 | PubMed |
| 14 | 36657728 | Two lineages of immune cells that differentially express the vitamin D receptor. | J Steroid Biochem Mol Biol | 2023 | https://conductscience.org/library/papers/36657728 | PubMed |
| 15 | 21746882 | 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. | Mol Cell Biol | 2011 | https://conductscience.org/library/papers/21746882 | PubMed |
| 16 | 27699227 | Elimination of p19ARF-expressing cells enhances pulmonary function in mice. | JCI Insight | 2016 | https://conductscience.org/library/papers/27699227 | PubMed |
| 17 | 28775044 | Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo. | Eur Respir J | 2017 | https://conductscience.org/library/papers/28775044 | PubMed |
| 18 | 26445902 | Detection of novel CYP11A1-derived secosteroids in the human epidermis and serum and pig adrenal gland. | Sci Rep | 2015 | https://conductscience.org/library/papers/26445902 | PubMed |
| 19 | 24836312 | A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24836312 | PubMed |
| 20 | 20643828 | miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. | J Exp Med | 2010 | https://conductscience.org/library/papers/20643828 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42960450 | Glycolysis in pulmonary fibrosis: From drivers to therapeutic opportunities (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42960450 | PubMed |
| 42765180 | Paricalcitol Attenuates Bleomycin-induced Pulmonary Fibrosis: Insights from Immunohistochemical and Molecular Genetic Analysis. | Endocr Metab Immune Disord Drug Targets | 2026 | https://conductscience.org/library/papers/42765180 | PubMed |
| 42724317 | CONUT score and Naples prognostic score (NPS) for dual prediction of survival and radiation toxicity in locally advanced non-small cell lung cancer with chemoradiotherapy. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42724317 | PubMed |
| 42653894 | The Therapeutic Efficacy of Inhaled Vitamin D3 Metabolites Initiated During the Acute Phase of Hypersensitivity Pneumonitis: An In Vivo Study. | Molecules | 2026 | https://conductscience.org/library/papers/42653894 | PubMed |
| 41784830 | Vitamin D receptor suppresses pulmonary fibroblast activation by downregulating the TGF-β1/Smad signaling pathway. | Histochem Cell Biol | 2026 | https://conductscience.org/library/papers/41784830 | PubMed |
| 40554453 | The value of macrolides in the adjuvant treatment of pulmonary fibrosis: maybe a panacea. | Ther Adv Respir Dis | 2025 | https://conductscience.org/library/papers/40554453 | PubMed |
| 40391214 | Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations. | Front Immunol | 2025 | https://conductscience.org/library/papers/40391214 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201632
GET https://conductscience.org/api/papers/v1/39201632/references?page=2